Correlation between echocardiographic left ventricular hypertrophy and microalbuminuria among hypertensive subjects in Olabisi Onabanjo university teaching hospital, Sagamu, Nigeria

Olajide O. Oresegun, Oluranti B. Familoni, Taiwo O. Olunuga, Akintunde Akinpelu


Background: Left ventricular hypertrophy is an adaptive response to volume and/or pressure overload, especially in hypertensive subjects. Microalbuminuria is a well-known predictor of poor cardiovascular outcomes in patients with hypertension. The purpose of this study was to determine the prevalence of microalbuminuria in hypertensive subjects and its relationship with LVH defined by echocardiogram in adult hypertensive subjects.

Methods: The study was a cross-sectional comparative one involving 88 hypertensive volunteers with age and sex-matched normotensive controls. Detailed history, physical examination, urine assessment for microalbuminuria and echocardiogram were carried out on all participants.

Results: The overall prevalence rate of microalbuminuria in the study was 29.5%. The prevalence of microalbuminuria in hypertensive subjects (43.2%) was significantly higher than in the normotensive counterparts (15.9%) (p=0.001). The prevalence of microalbuminuria in hypertensive subjects with echocardiographic LVH (81.0%) was significantly higher than in hypertensive participants without echocardiographic LVH (31.3%) (p=0.001). There was a positive correlation between left ventricular mass defined by echocardiogram and urinary albumin excretion in hypertensive subjects (r =0.422, p= 0.001).

Conclusions: There is a high prevalence of microalbuminuria among hypertensive adults, especially those with left ventricular hypertrophy. There is also a positive correlation between echocardiographic left ventricular mass and urinary albumin excretion among adult hypertensive subjects.


Echocardiogram, Hypertension, Left ventricular hypertrophy, Microalbuminuria

Full Text:



Santulli G. Epidemiology of Cardiovascular disease in the 21st century: Updated numbers and Update facts. Journal of cardiovascular disease. 2013; 1(1):1 -2.

Nadruz W. Myocardial remodeling in Hypertension. J Hum Hypertens.2015; 29(1): 1-6.

Marketou M.E, Parthenakis F, Vardas P.E. Pathological Left ventricular hypertrophy and stem cells: current evidence and new perspectives. Stem Cell International 2015, Article ID 578536.

American Diabetes Association: Standard of medical care in diabetes. Diabetes Care. 2005; 28:4-36.

Nabbaale J, Daris K, Emmanuel S, Elian S, James K, Peter L et al. Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patient: a cross sectional study from a tertiary Hospital in Uganda. BMC Research Notes. 2015; 8:198.

Odili AN. Prevalence and clinical correlates of microalbuminuria in newly diagnosed hypertensive subject .Nig J Med. 2008; 17(4):452-456.

Busari O, Opadijo G, Olanrewaju T, Omotosho A, Jimoh A. Electrocardiographic correlates of microalbuminuria in adult Nigerians with essential hypertension .Cardiol J. 2010; 17(3):281-287.

Herrera R, Almaguer M, Chipi J, Martinez O, Bacallao J, Rodriguez N, et al. Albuminuria as a marker of kidney and cardio-cerebral vascular damage. MEDDICC Rev 2010; 12(4):20- 26.

Monfared A, Salari A, Mirbolok F, Momeni M, Shafighnia S, Shakiba M, et al. Left ventricular hypertrophy and microalbuminuria in patients with essential hypertension. Iran J kidney Dis. 2013; 7(3):192-197

Dell’omo G, Giorgi D, Di Bello V, Miriani M, Pedrinelli R: Blood pressure independent association of microalbuminuria and LVH in hypertensive men. J Intern Med 2003; 254:76-84.

Kim YS, Kim HS, Oh HY, Lee MK, Kim CH, Kim YS, et al. Prevalence of microalbuminuria and associated risk factors among adult Korean hypertensive patients in a primary care setting. Hypertens Res. 2013;36(9): 807- 823.

Ogah O.S, Bamigboye A.E. Correlates of left ventricular mass in hypertensive Nigerians: an echocardiographic study. Cardiovasc J. Afr 2010; 21(2): 79-85.

Li L, Shigematsu Y, Hamada M, Hiwada K. Relative Wall Thickness Is an Independent Predictor of Left Ventricular Systolic and Diastolic Dysfunctions in Essential Hypertension. Hypertension Research 2001;24(5): 493 – 499.

Nwegbu MM, Akintan GA, Irabor EO. Prevalence of microalbuminuria in newly diagnosed hypertensive in a tertiary hospital setting using a semi-quantitative screening tool. Int. Res J Base Clin studies 2016; 4(1): 10-13

Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V. Body mass index, abdominal adiposity, and blood pressure: Consistency of their association across developing countries. Int J Obes Relat Metab Disord. 2002; 26: 48- 57.

Kannel WB. Risk Stratification in hypertension: New insight from the Framingham study. Am J Hypertens. 2000; 13: 3-10

Marques da silva P, Carvalho D, Nazare J, Martins L, Aguiar C. Prevalence of microalbuminuria in hypertensive patients with or without type II diabetes in a Portuguese Primary care setting: The RACE (MicRo Albuminuria screening survEy) study. Rev Port Cardio 2015; 34 (4): 237-46.

Agadah Z, Akpa M, Odia JO. Microalbuminuria and its correlation with Left ventricular mass index in untreated hypertensive patients in Port-Harcourt, Southern Nigeria. Br J Med Health Res. 2017; 4 (5).

Bibek P, Binod KY, Aishwini KN, Bhart K, Kanak BR. Prevalence and association of microalbuminuria in Essential hypertensive patients. N Am J Med Sci 2012; 4 (8): 331-335.

Ogbu ISI, Onah CE, Onwubere BJC, Exeugwunne IP. The prevalence of microalbuminuria among hypertensive patients attending University of Nigeria Teaching Hospital (UNTH) Enugu clinics. IOSR- JDMS 2013; 10 (4): 61 – 64

Afkhami-Ardekani M, Modarresi M, Amirchaghmaghi E. Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian J Nephrol. 2008;18(3): 112-117

Konta T, Hao Z, Abiko H, Ishikawa M, Takalashi T. Prevalence and risk factor analysis of micro albuminuria in Japanese general population: The Takalata study. Kidney Int. 2006: 70: 751-756

Satoru T, Hiroyuki T, Yasuaki D, Genjiro K. The prevalence and characteristics of microalbuminuria in the general population: a cross sectional study. BMC Res Notes. 2013; 6: 256.

Raja BA, Senthamaria A, Anandan H. Microalbuminuria and its correlation with left ventricular hypertrophy and retinopathy in Non-diabetic Hypertensive patients. Int J Sci study 2017; 5(2): 125-129.

Poudyal N, Ranale J, Srivastar B, Karki B, Basnet B. Frequency of microalbuminuria in hypertensive patients with left ventricular hypertrophy. PMJN 2010;10 (2): 42-44

Ratto E, Leoncini G, Viazzi F. Inappropriate Left Ventricular Mass is associated with microalbuminuria independent of Left Ventricular Hypertrophy in Primary Hypertension. J Hypertens 2008; 26: 34-50.

Sadeghi Ghahrodi M, Einollahi B. Microalbuminuria and left ventricular hypertrophy in essential hypertension: consequence or cause. IJKD 2013;7:169-177

Androulakis ES, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C. Essential hypertension: is there a role for inflammatory mechanisms? Cardiol Rev 2009; 17:216- 221.

Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: role of oxidative stress and Sgk1. Hypertension 2007;49: 355- 364.

Prujim MT, Madeleine G, Riesen WF, Burnier M, Bovet P. Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers. J Hypertens 2008; 26: 871- 877

Joshi VD, Nandkumar M, Lim J. Prevalence and risk factors of undetected proteinuria in an elderly South-East Asian population. Nephrology 2006; 11: 347- 354

Mattix HJ, Hsu Cy, Shaykevich S, Curhan G. Use of albumin/ creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002; 13:1034-9

Adebayo RA, Bamikole OJ, Balogun MO, Akintomide AO, Adeyeye VO. Echocardiographic assessment of left ventricular geometric patterns in Hypertensive patients in Nigeria. Clin Med Insights Cardiol. 2013;7:161-167

Maillet M, Van Berlo JH, Molkentin JD. Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol. 2013; 14(1): 38- 48.

Akintunde A, Akinwusi O, Opadijo G. Left ventricular hypertrophy, geometric patterns and clinical correlates among treated hypertensive Nigerians. Pan Afr J. 2010; 4: 8.

Adebiyi AA, Ogah OS, Aje A, Ojiji DB, Adebayo AK, Oladapo OO, et al. Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians. BMC Med Imaging 2006;6:10

Ojji DB, Opie LH, Lecour S, lacerda L, Adeyemi O, Sliwa K. Relationship between left ventricular Geometry and Soluble ST2 in Cohort of hypertensive patients. J Clin Hypertens (Greenwich). 2013; 15: 899-904

Hadiza S, Musa KK, Basil O. Pattern of left Ventricular geometry in Nigerian with Pre-hypertension. Nig. J Cardiol 2016; 13:18-22

Pierdomenico SD, Di Nicola M, Pierdomenico AM, Lapenna D, Cuccurullo F. Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis. J Hum Hypertens. 2011; 25(10): 585- 591